Examkin

Soru

Zorluk: OrtaAnxiety, OCD, and Trauma-Related Disorders

A 26-year-old woman is evaluated in the outpatient clinic for a two-month history of sudden, unpredictable episodes of overwhelming fear, palpitations, and a sensation of impending doom. These episodes reach their peak intensity within minutes and typically resolve after 15 to 20 minutes. Due to an intense fear of experiencing another episode in public, she has stopped using public transportation and avoids going to shopping malls. Her past psychiatric history is significant for a psychiatric hospitalization at age 21 for a severe manic episode involving grandiosity, rapid speech, and a decreased need for sleep. She was treated with a mood stabilizer at that time but discontinued the medication three years ago and has remained euthymic since. She also has a history of opioid use disorder and has been successfully maintained on buprenorphine-naloxone therapy for the past three years. Vital signs are within normal limits, and a recent comprehensive medical workup was unremarkable. Which of the following is the most appropriate next step in management?

  1. Initiate cognitive-behavioral therapyCevap
  2. B
    Initiate sertraline monotherapy
  3. C
    Initiate clonazepam
  4. D
    Initiate bupropion monotherapy
  5. E
    Initiate phenelzine monotherapy

Cevap

Initiate cognitive-behavioral therapy
The patient's presentation of recurrent, unexpected panic attacks followed by avoidance behavior is consistent with panic disorder and agoraphobia. First-line treatments for panic disorder include cognitive-behavioral therapy (CBT) and antidepressants (specifically SSRIs or SNRIs). However, this patient has a history of a severe manic episode, confirming a diagnosis of bipolar I disorder. In patients with bipolar disorder who are not currently taking a mood stabilizer, antidepressant monotherapy is strictly contraindicated due to the high risk of precipitating a manic switch. Additionally, she is on buprenorphine-naloxone for opioid use disorder, which makes benzodiazepines highly dangerous due to the risk of synergistic respiratory depression. Therefore, CBT is the safest and most effective first-line treatment for this patient's panic disorder, avoiding polypharmacy and serious adverse effects.

Adım Adım Çözüm

1
Identify the primary psychiatric diagnosis based on the clinical presentation.
The patient experiences recurrent, unexpected panic attacks and agoraphobia, confirming a diagnosis of Panic Disorder with Agoraphobia.
Establishing the correct primary diagnosis is necessary to determine the appropriate evidence-based treatment pathways.
2
Evaluate the patient's psychiatric and medical history for contraindications to standard pharmacotherapy.
The history reveals unmedicated Bipolar I Disorder and Opioid Use Disorder treated with buprenorphine.
Comorbidities significantly alter the safety profile of first-line treatments for panic disorder.
3
Select the safest first-line treatment that avoids adverse drug interactions and psychiatric complications.
Cognitive-behavioral therapy is selected over SSRIs (which risk manic switch) and benzodiazepines (which risk respiratory depression).
CBT provides effective, evidence-based treatment for panic disorder without the risks associated with polypharmacy in this complex patient.

Anahtar Kavram

Management of Panic Disorder with Agoraphobia in the context of psychiatric and substance use comorbidities
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Anxiety, OCD, and Trauma-Related Disorders

Bu konudan daha fazla soru